loadpatents
name:-0.023550033569336
name:-0.0079581737518311
name:-0.0089969635009766
BUCKL; Andreas Patent Filings

BUCKL; Andreas

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUCKL; Andreas.The latest application filed is for "bicyclic heteroaryl compounds and uses thereof".

Company Profile
7.2.12
  • BUCKL; Andreas - Redwood City CA
  • BUCKL; Andreas - San Francisco CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bicyclic Heteroaryl Compounds And Uses Thereof
App 20220135584 - BUCKL; Andreas ;   et al.
2022-05-05
Ras Inhibitors
App 20220105185 - AAY; Naing ;   et al.
2022-04-07
Bicyclic heteroaryl compounds and uses thereof
Grant 11,168,102 - Gill , et al. November 9, 2
2021-11-09
Bicyclic Heteroaryl Compounds And Uses Thereof
App 20210139517 - Gill; Adrian L. ;   et al.
2021-05-13
Ras Inhibitors
App 20210130303 - KOLTUN; Elena S. ;   et al.
2021-05-06
Ras Inhibitors
App 20210130369 - KOLTUN; Elena S. ;   et al.
2021-05-06
Ras Inhibitors
App 20210130326 - AGGEN; James ;   et al.
2021-05-06
2,5-disubstituted 3-methyl Pyrazines And 2,5,6-trisubstituted 3-methyl Pyrazines As Allosteric Shp2 Inhibitors
App 20210101870 - KOLTUN; Elena S. ;   et al.
2021-04-08
Polycyclic Compounds As Allosteric Shp2 Inhibitors
App 20200407372 - KOLTUN; Elena S. ;   et al.
2020-12-31
Pyridine, Pyrazine, And Triazine Compounds As Allosteric Shp2 Inhibitors
App 20200339552 - LI; Jie Jack ;   et al.
2020-10-29
2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
Grant 10,590,090 - Koltun , et al.
2020-03-17
Pyridine Compounds As Allosteric Shp2 Inhibitors
App 20200017517 - GILL; Adrian ;   et al.
2020-01-16
Bicyclic Compounds As Allosteric Shp2 Inhibitors
App 20200017511 - BLANK; Brian R. ;   et al.
2020-01-16
2,5-disubstituted 3-methyl Pyrazines And 2,5,6-trisubstituted 3-methyl Pyrazines As Allosteric Shp2 Inhibitors
App 20190210977 - JOGALEKAR; Ashutosh ;   et al.
2019-07-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed